Related Experiment Video
Updated: Oct 17, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Erythropoietin levels in children with obstructive sleep apnea
Nick D Kalogritsas1, Vasileios A Lachanas1, Panagiotis Liakos2
1Department of Otorhinolaryngology, University Hospital of Larissa, Greece.
Insights
Serum erythropoietin (EPO) levels are elevated in children with obstructive sleep apnea (OSA). These findings suggest EPO may serve as a potential biomarker for diagnosing pediatric OSA.
Area of Science:
- Pediatric Pulmonology
- Sleep Medicine
- Biomarker Discovery
Background:
- High serum erythropoietin (EPO) levels are documented in adult obstructive sleep apnea (OSA).
- Limited research exists on EPO levels in pediatric OSA.
- Investigating EPO as a pediatric OSA biomarker is warranted.
Purpose of the Study:
- To explore the relationship between serum EPO levels and pediatric OSA.
- To assess the potential of EPO as a diagnostic biomarker in children with OSA.
Main Methods:
- Prospective study involving children aged 4-12 years undergoing polysomnography (PSG).
- Recruited 115 children: 86 with OSA (mild, moderate, severe) and 29 without OSA (AHI≤1).
- Compared morning serum EPO levels between OSA and non-OSA groups.
Main Results:
- Children with OSA exhibited significantly higher mean serum EPO levels (8.33 ± 4.10 mIU/ml) compared to the non-OSA group (5.46 ± 2.29 mIU/ml).
- Serum EPO levels demonstrated a significant positive correlation with the apnea-hypopnea index (AHI) (p < 0.001).
Conclusions:
- Serum EPO levels are significantly elevated in children with OSA compared to controls.
- EPO shows promise as a potential biomarker for pediatric OSA.
- Further research is recommended due to the novelty of this finding.
Objective:
High serum erythropoietin (EPO) levels have been reported in adult patients with obstructive sleep apnea (OSA), however there is a lack of related literature in children with OSA. The main objective of this study was to explore the potential use of EPO as a pediatric OSA biomarker by exploring the relationship between serum EPO levels and the presence of pediatric OSA.
Methods And Materials:
A prospective study was conducted on children (4-12 years old) referred for overnight PSG. Thirty (30) consecutive children with mild. 30 consecutives with moderate, and 30 consecutives with severe OSA (OSA group), as well as 30 consecutive children with AHI≤1 (non-OSA group) were recruited. Morning blood specimens after PSG studies were obtained in order to compare EPO levels.
Results:
Finally, 115 children included for analysis. Non-OSA group consisted of 29 children (mean age: 6.93 ± 2.10) and OSA-group of 86 children (mean age: 6.78 ± 2.53). Mean EPO values for the non-OSA and OSA groups were 5.46 ± 2.29 mIU/ml and 8.33 ± 4.10 mIU/ml respectively. OSA-group had significant higher EPO levels than non-OSA (P: 0.01) while EPO levels were significantly correlated with AHI (p < 0.001).
Conclusion:
Our study showed that serum EPO levels of children with OSA are significantly higher than those without OSA and correlate significantly with AHI. These results suggest that EPO may be considered as a biomarker candidate for pediatric OSA. Since this may be the first study on the topic further research is needed.
Related Concept Videos
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Sleep Apnea
The condition is more prevalent among...
Erythropoiesis
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Factors Affecting Respiration
Heart Failure VI: Adjunct Therapies

